Scanning the RBD-ACE2 molecular interactions in Omicron variant

Biochem Biophys Res Commun. 2022 Feb 12:592:18-23. doi: 10.1016/j.bbrc.2022.01.006. Epub 2022 Jan 6.

Abstract

The emergence of new SARS-CoV-2 variants poses a threat to the human population where it is difficult to assess the severity of a particular variant of the virus. Spike protein and specifically its receptor binding domain (RBD) which makes direct interaction with the ACE2 receptor of the human has shown prominent amino acid substitutions in most of the Variants of Concern. Here, by using all-atom molecular dynamics simulations we compare the interaction of Wild-type RBD/ACE2 receptor complex with that of the latest Omicron variant of the virus. We observed a very interesting diversification of the charge, dynamics and energetics of the protein complex formed upon mutations. These results would help us in understanding the molecular basis of binding of the Omicron variant with that of SARS-CoV-2 Wild-type.

Keywords: Covid19; Molecular dynamics; SARS-CoV-2; Variants.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Substitution
  • Angiotensin-Converting Enzyme 2 / chemistry*
  • Angiotensin-Converting Enzyme 2 / metabolism*
  • COVID-19 / metabolism*
  • COVID-19 / virology*
  • Host Microbial Interactions / genetics
  • Host Microbial Interactions / physiology
  • Humans
  • Molecular Dynamics Simulation
  • Pandemics
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • SARS-CoV-2 / chemistry*
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / metabolism*
  • Spike Glycoprotein, Coronavirus / chemistry*
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / metabolism*
  • Static Electricity

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • SARS-CoV-2 variants